The total return over the past 12 months is +75.07% vs. +16.94% for the S&P 500. So far it's up +245.56% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +75.07% | +11.57% | (40.41%) | N/A | N/A | N/A |
| Total Return CAGR | +75.07% | +11.57% | (40.41%) | N/A | N/A | N/A |
| Revenue CAGR | (12.60%) | N/A | (11.98%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Korsana Biosciences, Inc. (KRSA)
| Year | Start price | End price | KRSA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $8.89 | $30.72 | +245.56% | +14.51% | +231.05% |
| 2025 | $22.54 | $8.89 | (60.56%) | +17.72% | (78.28%) |
| 2024 | $23.45 | $22.54 | (3.88%) | +24.89% | (28.77%) |
| 2023 | $91.84 | $23.45 | (74.47%) | +26.19% | (100.66%) |
| 2022 | $240.80 | $91.84 | (61.86%) | (18.17%) | (43.69%) |
| 2021 | $428.40 | $240.80 | (43.79%) | +28.74% | (72.53%) |
| 2020 | $380.80 | $428.40 | +12.50% | +18.37% | (5.87%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
